Trace amine-associated receptors and their ligands

British Journal of Pharmacology

Volumn 149, Issue 8, 2006, Pages 967-978

  Zucchi, R ^a,e   Chiellini, G ^a   Scanlan, T S ^b,c   Grandy, D K ^d  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e Sezione di Biochimica   (Italy)

Author keywords

Amphetamine; G protein coupled receptors; Signal transduction; Thyroid hormone; Thyronamines; Trace amines; Tyramine

Indexed keywords

ADRENALIN; AMPHETAMINE; CATECHOLAMINE DERIVATIVE; CYCLOHEXYLAMINE; DOPAMINE; G PROTEIN COUPLED RECEPTOR; HISTAMINE; HYDROXYAMPHETAMINE; LIGAND; METHAMPHETAMINE; N ETHYLAMPHETAMINE; NORADRENALIN; OCTOPAMINE; PHENETHYLAMINE; PSYCHOTROPIC AGENT; SEROTONIN; THYROID HORMONE DERIVATIVE; TRIMETHYLAMINE; TRYPTAMINE; TYRAMINE;

ADRENERGIC SYSTEM; BIPOLAR DISORDER; BODY TEMPERATURE; CONCENTRATION RESPONSE; GENE IDENTIFICATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HEART MUSCLE CONTRACTILITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SCHIZOPHRENIA; STRUCTURE ACTIVITY RELATION; THERMOREGULATION;

AMINO ACIDS; ANIMALS; HUMANS; LIGANDS; RECEPTORS, BIOGENIC AMINE; RECEPTORS, G-PROTEIN-COUPLED;

EID: 33845637306     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706948     Document Type: Review

References (112)

1. Abou Jamra R, Sircar I, Becker T, Freudenberg-Hua Y, Ohlraun S, Freudenberg J et al. (2005). A family-based and case-control association study of trace amine receptor genes on chromosome 6q23 in bipolar affective disorder. Mol Psychiatry 10: 618-620.
2. Amann D, Avidan N, Kanyas K, Kohn Y, Hamdan A, Ben-Hasher E et al. (2006). The trace amine receptor 4 gene is not associated with schizophrenia in a sample linked to chromosome 6q23. Mol Psychiatry 11: 119-121.
3. Axelrod J, Saavedra JM (1977). Octopamine. Nature 265: 501-504.
4. 3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine. J Pharmacol Exp Ther 235: 220-229.
5. Becu-Villalobos D, Thyssen SM, Rey EB, Lux-Lantos V, Libertun C (1992). Octopamine and phenylethylamine inhibit prolactin secretion both in vivo and in vitro. Proc Soc Exp Biol Med 199: 230-235.
6. Berry MD (2004). Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators. J Neurochem 90: 257-271.
7. Berry MD, Juorio AV, Li XM, Boulton AA (1996). Aromatic L-amino acid decarboxylase: a neglected and misunderstood enzyme. Neurochem Res 21: 1075-1087.
8. Blenau W, Balfanz S, Baumann A (2000). Amtryr 1: characterization of a gene from honeybee (Apis mellifera) brain encoding a functional tyramine receptor. J Neurochem 74: 900-908.
9. Blumenthal EM (2003). Regulation of chloride permeability by endogenously produced tyramine in the Drosophila malpighian tubule. Am J Physiol Cell Physiol 284: C718-C728.
10. Bly M (2005). Examination of the trace amine-associated receptor 2 (TAAR2). Schizophr Res 80: 367-368.
11. Boissier JR, Giudicelli JF, Larno S, Advenier C (1973). Differential inotropic-chronotropic action of thyronamine. Eur J Pharmacol 22: 141-149.
12. Borowsky B, Adham N, Jones KA, Raddaz R, Artymyshyn R, Ogozalek KL et al. (2001). Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci USA 98: 8966-8971.
13. Boulton AA (1980). Trace amines and mental disorders. Can J Neurol Sci 7: 261-263.
14. Branchek TA, Blackburn TP (2003). Trace amine receptors as targets for novel therapeutics: legend, myth and fact. Curr Opin Pharmacol 3: 90-97.
15. 3H]- tryptamine binding sites in various organs of the rat. Life Sci 34: 1441-1446.
16. Brunton L, Lazo J, Parker K (eds). (2005). Goodman, Gilman's The Pharmacological Basis of Therapeutics, 11th edn. McGraw-Hill: New York.
17. Bunzow JR, Sonders MS, Arttamangkul S, Harrison LM, Zhang GE, Quigley DI et al. (2001). Amphetamine, 3,4-methylenedioxy-methamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of the rat trace amine receptor. Mol Pharmacol 60: 1181-1188.
18. Buu-Hoi NP, Pham-Huu C, Petit L (1966). Some biological effects of thyronamine. Med Pharmacol Exp Int J Exp Med 15: 17-23.
19. Buu-Hoi NP, Pham-Huu C, Petit L (1969). Thyronamine, a new substance with long-lasting positive inotropic effect. Pharmacology 2: 281-287.
20. Cao Q, Martinez M, Zhang J, Sanders AR, Badner JA, Cravchik A et al. (1997). Suggestive evidence for a schizophrenia susceptibility locus on chromosome 6q and a confirmation in an independent series of pedigrees. Genomics 43: 1-8.
21. 3H] tryptamine binding sites in brain. Eur J Pharmacol 95: 31-39.
22. Chiellini G, Frascarelli S, Hart ME, Ronca-Testoni S, Scanlan TS, Zucchi R (2004). 3-Iodothyronamine is a novel endogenous modulator of cardiac inotropic state. Circulation 110: III-258.
23. Chiellini G, Frascarelli S, Hart ME, Ronca-Testoni S, Scanlan TS, Zucchi R (2005). Modulation of cardiac inotropic state by a novel thyroid hormone analog acting via non genomic mechanism. J Mol Cell Cardiol 38: 1086.
24. Cody V, Meyer T, Dohler KD, Hesch RD, Rokos H, Marko M (1984). Molecular structure and biochemical activity of 3,5,3′-triiodothyronamine. Endocr Res 10: 91-99.
25. Cote P, Polumbo RA, Harrison DC (1974). Thyronamine, a new inotropic agent: its cardiovascular effects and mechanism of action. Cardiovasc Res 8: 721-730.
26. D'Andrea G, Perini F, Terrazzino S, Nordera GP (2004). Contribution of biochemistry to the pathogenesis of primary headaches. Neurol Sci 25: S89-S92.
27. D'Andrea G, Terrazzino S, Fortin D, Farruggio A, Rinaldi L, Leon A (2003). HPLC electrochemical detection of trace amines in human plasma and platelets and expression of mRNA transcripts of trace amine receptors in circulating leukocytes. Neurosci Lett 346: 89-92.
28. Davenport AP (2003). Peptide and trace amine orphan receptors: prospects for new therapeutic targets. Curr Opin Pharmacol 3: 127-134.
29. David JC, Coulon JF (1985). Octopamine in invertebrates and vertebrates. A review. Prog Neurobiol 24: 141-185.
30. Davis BA, Boulton AA (1994). The trace amines and their acidic metabolites in depression - an overview. Prog Neuropsycopharmacol Biol Psychiatry 18: 17-45.
31. 2+ - ATPase activity. J Clin Invest 71: 579-586.
32. Davis PJ, Davis FB (1996). Nongenomic action of thyroid hormone. Thyroid 6: 497-504.
33. Davis PJ, Davis FB (2002). Nongenomic action of thyroid hormone on the heart. Thyroid 12: 459-466.
34. Dixon RAF, Kobilka BK, Strader DJ, Benovic JL, Dohlman HG, Frielle T et al. (1986). Cloning of the gene and cDNA for mammalian β-adrenergic receptor and homology with rhodopsin. Nature 321: 75-79.
35. Duan J, Martinez M, Sanders AR, Hou C, Saitou N, Kitano T et al. (2004). Polymorphisms in the trace amine receptor 4 (TRAR4) gene on chromosome 6q23.2 are associated with susceptibility to schizophrenia. Am J Hum Genet 75: 624-638.
36. Durden DA, Boulton AA (1988). Analysis of tryptamine at the femtomole level in tissue using negative ion chemical ionization gas chromatography-mass spectrometry. J Chromatogr 440: 253-259.
37. Durden DA, Philips SR (1980). Kinetic measurements of the turnover rates of phenylethylamine and tryptamine in vivo in the rat brain. J Neurochem 34: 1725-1732.
38. Durden DA, Philips SR, Boulton AA (1973). Identification and distribution of beta-phenylethylamine in the rat. Can J Biochem 51: 995-1002.
39. Dyck LE (1989). Release of some endogenous trace amines from rat striatal slices in the presence and absence of a monoamine oxidase inhibitor. Life Sci 44: 1149-1156.
40. Dyck LE, Yang CR, Boulton AA (1983). The biosynthesis of p-tyramine, m-tyramine, and beta phenylethylamine by rat striatal slices. J Neurosci Res 10: 211-220.
41. Evans PD, Robb S (1993). Octopamine receptor subtypes and their modes of action. Neurochem Res 18: 869-874.
42. Ewald H, Flint T, Kruse TA, Mors O (2002). A genome-wide scan shows significant linkage between bipolar disorder and chromosome 12q24.3 and suggestive linkage to chromosomes 1p22-21, 4p16, 6q14-22, 10q26 and 16p13.3. Mol Psychiatry 7: 734-744.
43. Falkenstein E, Tillmann HC, Christ M, Feuring M, Wehling M (2000). Multiple actions of steroid hormone - a focus on rapid, nongenomic effects. Pharmacol Rev 52: 513-556.
44. Federici M, Geracitano R, Tozzi A, Longone P, Di Angelantonio S, Bengtson CP et al. (2005). Trace amines depress GABA B response in dopaminergic neurons by inhibiting G-betagamma-inwardly rectifying potassium channels. Mol Pharmacol 67: 1283-1990.
45. Freudenberg-Hua Y, Freudenberg J, Kluck N, Cichon S, Propping P, Nöthen MM (2003). Single nucleotide variation analysis in 65 candidate genes for CNS disorders in a representative sample of the European population. Genome Res 13: 2271-2276.
46. Gerhardt CC, Bakker RA, Piek GJ, Planta RJ, Vreugdenhill E, Leysen JE et al. (1997). Molecular cloning and pharmacological characterization of a molluscan octopamine receptor. Mol Pharmacol 51: 293-300.
47. Gloriam DEI, Bjarnadottir TK, Schiöth HB, Fredriksson R (2005a). High species variation within the repertoire of trace amine receptors. Ann NY Acad Sci 1040: 323-327.
48. Gloriam DEI, Bjarnadottir TK, Yan YL, Postlethwait JH, Schiöth HB, Fredriksson R (2005b). The repertoire of trace amine G-protein-coupled receptors: large expansion in zebrafish. Mol Phylogenesis Evol 35: 470-482.
49. Grohmann L, Blenau W, Erber J, Ebert PR, Strunker T, Baumann A (2003). Molecular and functional characterization of an octopamine receptor from honeybee (Apis mellifera) brain. J Neurochem 86: 725-735.
50. Hart ME, Suchland KL, Miyakawa M, Bunzow JR, Grandy DK, Scanlan TS (2006). Trace amine-associated receptor agonists: synthesis and evaluation of thyronamines and related analogues. J Med Chem 49: 1101-1112.
51. 3H]beta- phenylethylamine binding sites in rat brain. Eur J Pharmacol 83: 147-148.
52. Hill SJ (2006). G-protein-coupled receptors: past, present and future. Br J Pharmacol 147: S27-S37.
53. Ibrahim KE, Couh MW, Williams CW, Fregly MJ, Midgley JM (1985). m-Octopamine: normal occurrence with p-octopamine in mammalian sympathetic nerves. J Neurochem 44: 1862-1867.
54. Ikeda M, Iwara N, Suzuki T, Kitajima T, Yamanouchi Y, Kinoshita Y et al. (2005). No association of haplotype-tagging SNPs in TRAR4 with schizophrenia in Japanese patients. Schizophr Res 78: 127-130.
55. Ikemoto H, Hiroshige T, Itoh S (1967). Oxygen consumption of brown adipose tissue in normal and hypothyroid mice. Jpn J Physiol 17: 516-522.
56. Ishida K, Murata M, Kato M, Utsunomiya I, Hoshi K, Taguchi K (2005). Beta-phenylethylamine stimulates striatal acetylcholine release through activation of the AMPA glutamatergic pathway. Biol Pharm Bull 28: 1626-1629.
57. Jones RSG (1983). Trace biogenic amines: a possible functional role in the CNS. Trends Pharmacol Sci 4: 426-429.
58. Kinniburgh DW, Boyd ND (1979). Determination of plasma octopamine and its level in renal disease. Clin Biochem 12: 27-32.
59. Kosa E, Marcilhac-Flouriot A, Fache MP, Siaud P (2000). Effects of beta-phenylethylamine on the hypothalamo-pituitary-adrenal axis in the male rat. Pharmacol Biochem Behav 67: 527-535.
60. Laakso A, Pohjalainen T, Bergman J, Kajander J, Haaparanta M, Solin O et al. (2005). The A1 allele of the human D2 dopamine receptor gene is associated with increased activity of striatal L-amino acid decarboxylase in healthy subjects. Pharmacogenet Genom 15: 387-391.
61. Lefkowitz RJ (2004). Historical review: a brief history and personal retrospective of seven-transmembrane receptors. Trends Pharmacol Sci 25: 413-422.
62. Levinson DF, Holmans P, Straub RE, Owen MJ, Wildenauer DB, Gejman PV et al. (2000). Multicenter linkage study of schizophrenia candidate regions on chromosomes 5q, 6q, 10p, and 13q: schizophrenia linkage collaborative group III. Am J Hum Genet 67: 652-663.
63. Levy M (1988). Effects of octopamine on renal function in anaesthetized dogs. Clin Invst Med 11: 396-402.
64. Lewin A (2006). Receptors of mammalian trace amines. AAPS J 8: E138-E145.
65. Liberles SD, Buck LB (2006). A second class of chemosensory receptors in the olfactory epithelium. Nature 442: 645-650.
66. Lindemann L, Ebeling M, Kratochwil NA, Bunzow JR, Grandy DK, Hoener MC (2005). Trace amine associated receptors form structurally and functionally distinct subfamilies of novel G protein-coupled receptors. Genomics 85: 372-385.
67. Lindemann L, Hoener M (2005). A renaissance in trace amines inspired by a novel GPCR family. Trends Pramacol Sci 26: 274-281.
68. Locock RA, Baker GB, Coutts RT, Dewhurst WG (1984). Displacement of serotonin from binding sites in rat cortex: the effects of biogenic 'trace' amines. Prog Neuropsychopharmacol Biol Psychiatry 8: 701-704.
69. McClung C, Hirsh J (1999). The trace amine tyramine is essential for sensitization to cocaine in Drosophila. Curr Biol 9: 853-860.
70. McCormack JK, Beitz AJ, Larson AA (1986). Autoradiographic localization of tryptamine binding sites in the rat and dog central nervous system. J Neurosci 6: 94-101.
71. Meyer T, Hesch RD (1983). Triiodothyronamine - a beta adrenergic metabolite of triiodothyronine? Horm Met Res 15: 602-606.
72. Miller GM, Verrico CD, Jassen A, Konar M, Yang H, Panas H et al. (2005). Primate trace amine receptor 1 modulation by the dopamine transporter. J Pharmacol Exp Ther 313: 983-995.
73. Morin N, Visentin V, Calise D, Marti L, Zorzano A, Testar X et al. (2002). Tyramine stimulates glucose uptake in insulin-sensitive tissues in vitro and in vivo via its oxidation by amine oxidase. J Pharmacol Exp Ther 303: 1238-1247.
74. 3H]tryptamine binding site in human brain. Prog Brain Res 106: 285-291.
75. Mousseau DD, Butterworth RF (1995b). Trace amines in hepatic encephalopathy. Prog Brain Res 106: 277-284.
76. Mowry BJ, Nancarrow DJ (2001). Molecular genetics of schizophrenia. Clin Exp Pharmacol Physiol 28: 66-69.
77. Nguyen TV, Juorio AV (1989). Binding sites for brain trace amines. Cell Mol Neurobiol 9: 277-311.
78. Parker EM, Cubeddu LX (1988). Comparative effects of amphetamine, phenylethylamine and related drugs on dopamine efflux, dopamine uptake and mazindol binding. J Pharmacol Exp Ther 245: 199-210.
79. Paterson IA, Juorio AV, Boulton M (1990). 2-Phenylethylamine: a modulator of catecholamine transmission in the mammalian central nervous system? J Neurochem 55: 1827-1837.
80. Pelacios JM, O'Dowd BF, Cotecchia S, Hnatowich M, Caron MG, Lefkowitz RJ (1989). Adrenergic receptors homologies in vertebrate and invertebrate species examined by DNA hybridization. Life Sci 44: 2057-2065.
81. Philips SR, Boulton AA (1979). The effect of monoamine oxidase inhibitors on some arylalkylamines in rat striatum. J Neurochem 33: 159-167.
82. Philips SR, Durden DA, Boulton AA (1974). Identification and distribution of p-tyramine in the rat. Can J Biochem 52: 366-373.
83. Premont RT, Gainetdinov RR, Caron MG (2001). Following the trace of elusive amines. Proc Natl Acad Sci USA 98: 9474-9475.
84. Rahman AR, Lang CC, Struthers AD (1995). The effect of enalapril on tyramine induced changes in renal function in man. Int J Clin Pharmacol Ther 33: 404-409.
85. Raiteri M, Del Carmine R, Bertollini A, Levi G (1977). Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine. Eur J Pharmacol 41: 133-143.
86. Reynolds GP (1979). Phenylethylamine - a role in mental illness? Trends Neurosci 2: 265-268.
87. Rice JP, Goate A, Williams JT, Bierut L, Dorr D, Wu W et al. (1997). Initial genome scan of the NIMH genetics initiative bipolar pedigrees: chromosomes 1, 6, 8, 10, and 12. Am J Med Genet 74: 247-253.
88. Roeder T (1999). Octopamine in invertebrates. Prog Neurobiol 59: 533-541.
89. Saavedra JM, Axelrod J (1973). Effect of drugs on the tryptamine content of rat tissues. J Pharmacol Exp Ther 185: 523-529.
90. Saavedra JM, Coyle JT, Axelrod J (1973). The distribution and properties of the nonspecific N-methyltransferase in brain. J Neurochem 20: 743-752.
91. Saavedra JM, Palkovits M, Brownstein MJ, Axelrod J (1974). Localisation of phenylethanolamine N-methyl transferase in the rat brain nuclei. Nature 248: 695-696.
92. Saraswati S, Fox LE, Soll DR, Wu CF (2004). Tyramine and octopamine have opposite effects on the locomotion of Drosophila larvae. J Neurobiol 58: 425-441.
93. Saudou F, Amlaiki N, Plassat JL, Borrelli E, Hen R (1990). Cloning and characterization of a Drosophila tyramine receptor. EMBO J 9: 3611-3617.
94. Scanlan TS, Suchland KL, Hart ME, Chiellini G, Huang Y, Kruzich PJ et al. (2004). 3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone. Nat Med 10: 638-642.
95. Schildkraut JJ (1976). The catecholamine hypothesis of affective disorders. A review of supporting evidence. Int J Psychiatry 4: 203-217.
96. Schwab SG, Hallmayer J, Albus M, Lerer B, Eckstein GN, Borrmann M et al. (2000). A genome-wide autosomal screen for schizophrenia susceptibility loci in 71 families with affected siblings: support for loci on chromosome 10p and 6. Mol Psychiatry 5: 638-649.
97. Segal J, Ingbar SH (1989). 3,5,3′-Triiodothyronine increases 3′,5′-monophoshate concentration and sugar uptake in rat thymocytes by stimulating adenylate cyclase activity: studies with the adenylate cyclase inhibitor MDL 12330A. Endocrinology 124: 2166-2171.
98. Shi L, Javitch JA (2002). The binding site of aminergic G protein-coupled receptors: the transmembrane segments and second extracellular loop. Annu Rev Pharmacol Toxicol 42: 437-467.
99. Usdin E, Sandler M (eds) (1976). Trace Amines and the Brain. Dekker: New York.
100. 3H]-tyramine in the central nervous system. Br J Pharmacol 89: 15-25.
101. Vanderwolf CH, Robinson TE, Pappas BA (1980). Monoamine replacement after reserpine: catecholaminergic agonists restore motor activity but phenylelthylamine restores atropineresistant neocortical low voltage fast activity. Brain Res 202: 65-77.
102. Vanti WB, Muglia P, Nguyen T, Cheng R, Kennedy JL, George SR et al. (2003). Discovery of a null mutation in a human trace amine receptor gene. Genomics 82: 531-536.
103. Venken T, Alaerts M, Adolfsson R, Broeckhoven CV, Del Favero J (2006). No association of trace amine-associated receptor 6 with bipolar disorder in a northern Swedish population. Psychiatr Gent 16: 1-2.
104. Venter JC, Eddy B, Hall LM, Fraser CM (1984). Monoclonal antibodies detect the conservation of muscarinic cholinergic receptor structure from Drosophila to human brain and detect possible structural homology with alpha 1-adrenergic receptors. Proc Natl Acad Sci USA 81: 272-276.
105. Visentin V, Morin N, Fontana E, Prevot D, Boucher J, Castan I et al. (2001). Dual action of octopamine on glucose transport into adipocytes: inhibition via beta3-adrenoceptor activation and stimulation via oxidation by amine oxidase. J Pharmacol Exp Ther 299: 96-104.
106. Wolinsky TD, Swanson CJ, Zhong H, Smith KE, Branchek TA, Gerald CP (2004). Deficit in prepulse inhibition and enhanced sensitivity to amphetamine in mice lacking the trace amine-1 receptor. Neuropsychopharmacology 29: S231.
107. Wu SY, Green WL, Huang WS, Hays MT, Chopra IJ (2005). Alternate pathways of thyroid hormone metabolism. Thyroid 15: 943-958.
108. Yalcin Y, Carman D, Shao Y, Ismail-Beigi F, Klein I, Ojamaa K (1999). Regulation of Na/K-ATPase gene expression by thyroid hormone and hyperkalemia in the heart. Thyroid 9: 53-59.
109. Yang HY, Neff NH (1973). Beta-phenylethylamine: a specific substrate for type B monoamine oxidase of brain. J Pharmacol Exp Ther 187: 365-371.
110. Yen PM (2001). Physiological and molecular basis of thyroid hormone action. Physiol Rev 81: 1097-1142.
111. Yu AM, Granvil CP, Haining RL, Krausz KW, Corchero J, Kupfer A et al. (2003). The relative contribution of monoamine oxidase and cytochrome p450 isozymes to the metabolic deamination of the trace amine tryptamine. J Pharmacol Exp Ther 304: 539-546.
112. Zhu MY, Juorio AV (1995). Aromatic L-amino acid decarboxylase: biological characterization and functional role. Gen Pharmacol 26: 681-696.